Their patented microfluidic bioreactor allows for the production of mature blood cells under controlled conditions, providing patients with improved platelet purity and immune-compatible human platelets for transfusion therapy. PlateletBio is an allogeneic cell therapy company focused on platelet biology, creating a new category in therapeutics to tackle previously unmet medical challenges.